HCA Healthcare, Inc. $HCA Shares Newly Purchased by Sanders Morris Harris LLC

Key Points

• Sanders Morris Harris LLC acquired 3,778 HCA Healthcare shares worth approximately $1.61 million, while institutional investors collectively own 62.73% of the company.
• HCA shares recently traded at $470.25, near the analyst consensus price target of $467.61. The stock has a “Moderate Buy” consensus rating, with 16 Buy, seven Hold, and one Sell rating.
• HCA exceeded quarterly expectations with $7.59 in earnings per share and $20.23 billion in revenue, while revenue increased 8.7% year over year. The company also pays a quarterly dividend of $0.78 per share, representing a 0.7% yield.

Sanders Morris Harris LLC acquired a new position in HCA Healthcare, Inc. (NYSE:HCA - Free Report) during the third quarter, according to the company in its most recent filing with the SEC. The fund acquired 3,778 shares of the company's stock, valued at approximately $1,613,000.

Other large investors have also recently bought and sold shares of the company. Sunbelt Securities Inc. increased its position in HCA Healthcare by 171.7% in the 1st quarter. Sunbelt Securities Inc. now owns 6,242 shares of the company's stock valued at $2,954,000 after acquiring an additional 3,945 shares during the period. Sei Investments Co. increased its position in shares of HCA Healthcare by 27.5% in the first quarter. Sei Investments Co. now owns 467,796 shares of the company's stock worth $221,380,000 after acquiring an additional 100,764 shares in the last quarter. Oddo BHF Asset Management Sas raised its holdings in shares of HCA Healthcare by 40.8% during the fourth quarter. Oddo BHF Asset Management Sas now owns 9,760 shares of the company's stock valued at $4,557,000 after acquiring an additional 2,829 shares during the period. SEB Asset Management AB purchased a new stake in shares of HCA Healthcare in the 1st quarter valued at approximately $75,534,000. Finally, OP Asset Management Ltd acquired a new position in HCA Healthcare in the 1st quarter worth approximately $12,883,000. Institutional investors own 62.73% of the company's stock.

HCA Healthcare Stock Performance

Shares of HCA Healthcare stock traded up $9.50 during trading on Wednesday, hitting $470.25. 1,081,387 shares of the stock traded hands, compared to its average volume of 1,340,885. The stock has a market cap of $101.81 billion, a P/E ratio of 15.74, a PEG ratio of 1.55 and a beta of 1.10. The company has a fifty day moving average price of $423.07 and a two-hundred day moving average price of $419.09. HCA Healthcare, Inc. has a twelve month low of $353.99 and a twelve month high of $556.52.

HCA Healthcare (NYSE:HCA - Get Free Report) last posted its earnings results on Friday, July 24th. The company reported $7.59 EPS for the quarter, topping the consensus estimate of $7.56 by $0.03. The company had revenue of $20.23 billion during the quarter, compared to the consensus estimate of $19.76 billion. HCA Healthcare had a net margin of 8.77% and a negative return on equity of 244.79%. The company's revenue for the quarter was up 8.7% compared to the same quarter last year. During the same period in the previous year, the firm posted $6.84 earnings per share. On average, equities research analysts expect that HCA Healthcare, Inc. will post 29.42 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, September 30th. Stockholders of record on Wednesday, September 16th were issued a dividend of $0.78 per share. The ex-dividend date of this dividend was Wednesday, September 16th. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.7%. HCA Healthcare's dividend payout ratio is currently 10.45%.

Analyst Ratings Changes

HCA has been the subject of a number of research analyst reports. Sanford C. Bernstein restated a "market perform" rating on shares of HCA Healthcare in a report on Wednesday, July 15th. Weiss Ratings raised HCA Healthcare from a "hold (c+)" rating to a "buy (b-)" rating in a research note on Thursday, October 8th. BMO Capital Markets began coverage on HCA Healthcare in a research note on Tuesday, September 22nd. They set an "outperform" rating and a $495.00 target price on the stock. The Goldman Sachs Group dropped their target price on HCA Healthcare from $558.00 to $485.00 and set a "buy" rating on the stock in a report on Tuesday, July 28th. Finally, Wells Fargo & Company boosted their price target on shares of HCA Healthcare from $369.00 to $381.00 and gave the company an "equal weight" rating in a report on Monday, August 3rd. Sixteen equities research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the company's stock. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average price target of $467.61.

HCA Healthcare Company Profile

HCA Healthcare, Inc is a provider of healthcare services in the United States. Through its network of hospitals and other healthcare facilities, the company delivers services including emergency and urgent care, surgery, inpatient and outpatient treatment, women's and children's care, cardiology, oncology, orthopedics, and behavioral health services.

HCA Healthcare also operates physician practices, ambulatory surgery centers, freestanding emergency rooms, diagnostic facilities, and other outpatient care sites.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.